Effects of European Society of Cardiology guidelines on medication profiles after hospitalization for heart failure in 22,476 Dutch patients: from 2001 until 2015-Reference-Cited by-同舟云学术

Effects of European Society of Cardiology guidelines on medication profiles after hospitalization for heart failure in 22,476 Dutch patients: from 2001 until 2015

Published:2019-03-08 Issue:4 Volume:24 Page:499-510
ISSN:1382-4147
Container-title:Heart Failure Reviews
language:en
Short-container-title:Heart Fail Rev

Author:

Kruik-Kollöffel Willemien J.^ORCID,Linssen Gerard C.M.,Kruik H. Joost,Movig Kris L.L.,Heintjes Edith M.,van der Palen Job

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10741-019-09777-2.pdf

Reference33 articles.

1. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, Van der Meer P (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18(8):891–975

2. Bouvy ML, Heerdink ER, Leufkens HG, Hoes AW (2003) Patterns of pharmacotherapy in patients hospitalised for congestive heart failure. Eur J Heart Fail 5(2):195–200

3. Eschalier R, Chenaf C, Mulliez A, Yalioua A, Clerfond G, Authier N, Vorilhon C, Citron B, Pereira B, Jean F, Souteyrand G, Motreff P, Eschalier A, Lusson JR (2015) Impact of clinical characteristics and management on the prognosis of unselected heart failure patients. Cardiovasc Drugs Ther 29(1):89–98. https://doi.org/10.1007/s10557-015-6572-y

4. Gilstrap LG, Fonarow GC, Desai AS, Liang L, Matsouaka R, DeVore AD, Smith EE, Heidenreich P, Hernandez AF, Yancy CW, Bhatt DL (2017) Initiation, continuation, or withdrawal of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and outcomes in patients hospitalized with heart failure with reduced ejection fraction. J Am Heart Assoc 6(2):e004675

5. Koudstaal S, Pujades-Rodriguez M, Denaxas S, Gho JMIH, Shah AD, Yu N, Patel RS, Gale CP, Hoes AW, Cleland JG, Asselbergs FW, Hemingway H (2017) Prognostic burden of heart failure recorded in primary care, acute hospital admissions, or both: a population-based linked electronic health record cohort study in 2.1 million people. Eur J Heart Fail 19(9):1119–1127

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of sacubitril/valsartan in patients with heart failure in primary care in Germany: the AURORA-HF noninterventional study;Herz;2024-04-24

2. Association between Incidence of Prescriptions for Alzheimer’s Disease and Beta-Adrenoceptor Antagonists: A Prescription Sequence Symmetry Analysis;Pharmaceuticals;2023-12-06

3. Non-cardiovascular medication and readmission for heart failure: an observational cohort study;International Journal of Clinical Pharmacy;2022-05-28

4. Treatment prescription, adherence, and persistence after the first hospitalization for heart failure: A population-based retrospective study on 100785 patients;International Journal of Cardiology;2021-05

5. Factors associated with non-use and sub-target dosing of medical therapy for heart failure with reduced ejection fraction;Heart Failure Reviews;2021-01-20